- You can view the full Endo Health Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.
After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.
As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?
New York City sues Purdue Pharma, Teva Pharmaceutical, Allergan, Johnson and Johnson, Endo International, McKesson, AmerisourceBergen and Cardinal Health over how opioids have devastated the city and its services.
A group of hospital systems led by Intermountain Healthcare said Jan. 18 they are planning to form a not-for-profit generic drug firm to address drug shortages and high costs.